Evidence map›Paper›PMID 41290615›Full record

ArticleNature communications2025

A de novo missense variant in MIDEAS results in increased deacetylase activity of the MiDAC HDAC complex causing a neurodevelopmental syndrome.

Louise Fairall, Kristupas Sirvydis, Robert E Turnbull, Suzan Jg Knottnerus, Oksana Gonchar, Frederick W Muskett, Rebekah Jukes-Jones, Lonneke van Brussel, Ellen van de Geer, Koen van Gassen and 6 more

Abstract readCase Reports
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Louise Fairall *Institute for Structural and Chemical Biology, Department of Molecular and Cell Biology, University of Leicester, Leicester, UK.ORCID http://orcid.org/0000-0001-9456-3047
Kristupas Sirvydis *Institute for Structural and Chemical Biology, Department of Molecular and Cell Biology, University of Leicester, Leicester, UK.ORCID http://orcid.org/0000-0002-6337-3504
Robert E Turnbull *Institute for Structural and Chemical Biology, Department of Molecular and Cell Biology, University of Leicester, Leicester, UK.ORCID http://orcid.org/0000-0003-2863-4374
Suzan Jg Knottnerus *Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Oksana GoncharInstitute for Structural and Chemical Biology, Department of Molecular and Cell Biology, University of Leicester, Leicester, UK.
Frederick W MuskettInstitute for Structural and Chemical Biology, Department of Molecular and Cell Biology, University of Leicester, Leicester, UK.ORCID http://orcid.org/0000-0003-1303-0009
Rebekah Jukes-JonesInstitute for Structural and Chemical Biology, Department of Molecular and Cell Biology, University of Leicester, Leicester, UK.
Lonneke van BrusselDepartment of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Ellen van de GeerDepartment of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Koen van GassenDepartment of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Paul BadenhorstInstitute of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, UK.ORCID http://orcid.org/0000-0002-2542-0250
Diana JohnsonDepartment of Clinical Genetics, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
Paulien A TerhalDepartment of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Peter M van HasseltDepartment of Metabolic Disease, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, the Netherlands.
Richard H van JaarsveldDepartment of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. R.H.vanJaarsveld@umcutrecht.nl.ORCID http://orcid.org/0000-0001-5247-6965
John Wr SchwabeInstitute for Structural and Chemical Biology, Department of Molecular and Cell Biology, University of Leicester, Leicester, UK. john.schwabe@leicester.ac.uk.ORCID http://orcid.org/0000-0003-2865-4383

Funding

Wellcome Trust 222493Wellcome Trust (Wellcome) 222493/Z/21/Z
6 · The paper itself

Abstract

MIDEAS is a scaffold protein that, together with DNTTIP1, mediates assembly of the MiDAC histone deacetylase complex. Mice lacking MiDAC die before birth suggesting a key developmental function. Here, we report two unrelated individuals, with a multisystem disorder characterised by delayed speech development, joint contractures, dysmorphic features and dysmotility of the gut. Both individuals have the same de novo heterozygous missense variant in MIDEAS (p.Tyr654Ser). A cryoEM structure of the MiDAC complex reveals that this amino acid is located in a conserved auto-inhibitory loop that covers the active site of the deacetylase enzyme. We suggest that the variant results in loop displacement leading to elevated deacetylase activity. In support, we observe reciprocal gene expression changes in patient fibroblasts compared with a cell line following rapid MiDAC degradation. Our results establish MIDEAS as a dominant monogenic disease gene and that hyperactivity of the MiDAC complex results in a characteristic multisystem disorder.

Indexed as

Histone DeacetylasesMutation, MissenseNeurodevelopmental DisordersAnimalsChildChild, PreschoolCryoelectron MicroscopyFemaleFibroblastsHumansMaleMiceHistone Deacetylases

Identifiers

PMID41290615
PMCPMC12647621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.